NAUT logo

NAUTNautilus Biotechnology Inc

$2.24
$0.045
(1.97%)
Today
Closed $2.24
$0.00
(0.00%)
After Hours
Updated: 04:25 PM EDT
EarningsJul 30
Mkt Cap$290.38M
Vol440,147.00
News
all
press releases
Nautilus Biotechnology Q1 Earnings Call Highlights
Nautilus Biotechnology (NASDAQ:NAUT) reported first-quarter 2026 results and highlighted progress toward its planned commercialization timeline, with management emphasizing expanding early customer...
MarketBeat
News Placeholder
More News
News Placeholder
Nautilus Biotechnology (NASDAQ:NAUT) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS
Nautilus Biotechnology (NASDAQ:NAUT - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.12) earnings per share for the quarter, beating the consensus...
MarketBeat
News Placeholder
Nautilus Biotechnology Reports Q1 2026 Results: Full Earnings Call Transcript
read more...
Benzinga
News Placeholder
Sentinel Trust Co. LBA Purchases New Position in Nautilus Biotechnology, Inc. $NAUT
Sentinel Trust Co. LBA purchased a new stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 750,000 shares of the company's stock, valued at approxi...
MarketBeat
News Placeholder
Nautilus Biotechnology (NAUT) Expected to Announce Earnings on Tuesday
Nautilus Biotechnology (NASDAQ:NAUT) will be releasing its Q1 2026 earnings before the market opens on Tuesday, April 28. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-28-nautilus-biotechnology-inc-stock...
MarketBeat
News Placeholder
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Sees Significant Increase in Short Interest
Nautilus Biotechnology, Inc. (NASDAQ:NAUT - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totaling 674,952 shares, an increase of 51.1% from the March 15th total of 446,652 shares. Approximately 0.9% of...
MarketBeat
News Placeholder
Nautilus Biotechnology Unveils Voyager Proteomics Platform, Targets Beta Access in 2H and Launch Next Year
Nautilus Biotechnology (NASDAQ:NAUT) executives outlined the company's strategy to unlock the power of the proteome and argued that better protein measurement tools could improve drug development...
MarketBeat
News Placeholder
Nautilus Biotechnology (NASDAQ:NAUT) Sets New 52-Week High - What's Next?
Nautilus Biotechnology (NASDAQ:NAUT) Reaches New 12-Month High - Time to Buy...
MarketBeat
News Placeholder
Sujal Patel Buys 25,000 Shares of Nautilus Biotechnology (NASDAQ:NAUT) Stock
Nautilus Biotechnology, Inc. (NASDAQ:NAUT - Get Free Report) CEO Sujal Patel bought 25,000 shares of the firm's stock in a transaction on Wednesday, March 4th. The shares were acquired at an average...
MarketBeat
News Placeholder
Nautilus Biotechnology (NASDAQ:NAUT) Price Target Raised to $4.00 at Guggenheim
Guggenheim upped their target price on Nautilus Biotechnology from $2.50 to $4.00 and gave the stock a "buy" rating in a report on Friday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.